A recent study reveals that individuals who come off popular slimming jabs like semaglutide or tirzepatide can put back on shed pounds far faster than those who end conventional lifestyle programs.
Published data in a prominent health publication demonstrates that while obese people often shed a large proportion of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these medications should be cognizant of the danger of quick rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
Such speed of regain means a reversion to starting mass within about a year and a half.
Analyzing Treatments
The study, which examined dozens of studies involving thousands of patients, contrasted the outcomes of these new drugs with other pills.
Scientists note that people who shed pounds through lifestyle changes alone typically see a less rapid creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Fast Regain
Nutrition scientists suggest the mechanism of the injections accounts for the amplified rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls hunger.
"Artificially providing the hormone levels far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement results in appetite is uncontrolled, making binge eating a significant risk."
A Chronic Disease?
Health authorities recommend the injections for people with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians argue that, due to the likelihood of relapse, the therapy is often long-term.
This perspective is echoed by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," similar to managing conditions like high blood pressure.
Patient Testimonies
People who have stopped the jabs describe a intense return of cravings.
"I experienced a switch activating and you become ravenous," described one woman.
The struggle is exacerbated if users have not established sustainable lifestyle or habit modifications during treatment.
Significant Use
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Use is higher among women compared to males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, researchers stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic cure and maintained weight loss likely depends on combined behavioural support.
